Cumberland Pharmaceuticals (CPIX) Inventory Average (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) reported Inventory Average of $5.8 million for Q1 2026, up 44.21% on a YoY basis from $4.0 million in Q1 2025, and up 27.5% sequentially from $4.6 million in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Inventory Average (2011 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 16 years of Inventory Average data on file, last reported at $5.8 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average rose 44.21% year-over-year to $5.8 million; the trailing twelve-month figure through Mar 2026 stood at $5.8 million (up 44.21% YoY), and the FY2025 full-year result was $5.1 million, up 18.77% from the prior year.
- Inventory Average advanced to $5.8 million in Q1 2026, from $4.6 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $10.6 million in Q2 2023 to a low of $3.1 million in Q3 2025.
- A 5-year average of $6.8 million and a median of $5.8 million in 2026 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average slumped 59.12% in 2024 and surged 44.21% in 2026, its largest moves.
- Tracing CPIX's Inventory Average over 5 years: stood at $10.3 million in 2022, then plunged by 35.26% to $6.6 million in 2023, then sank by 35.92% to $4.3 million in 2024, then grew by 7.65% to $4.6 million in 2025, then rose by 27.5% to $5.8 million in 2026.
- Business Quant data shows CPIX's Inventory Average at $5.8 million in Q1 2026, $4.6 million in Q4 2025, and $3.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn | 5.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.84 Mn |
| Dec 31, 2025 | 4.58 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 3.66 Mn |
| Mar 31, 2025 | 4.05 Mn |
| Dec 31, 2024 | 4.25 Mn |
| Sep 30, 2024 | 4.41 Mn |
| Jun 30, 2024 | 4.31 Mn |
| Mar 31, 2024 | 4.47 Mn |
| Dec 31, 2023 | 6.64 Mn |
| Sep 30, 2023 | 9.80 Mn |
| Jun 30, 2023 | 10.55 Mn |
| Mar 31, 2023 | 10.02 Mn |
| Dec 31, 2022 | 10.26 Mn |
| Sep 30, 2022 | 10.03 Mn |
| Jun 30, 2022 | 9.65 Mn |
| Mar 31, 2022 | 9.15 Mn |
| Dec 31, 2021 | 9.35 Mn |
| Sep 30, 2021 | 10.18 Mn |
| Jun 30, 2021 | 10.06 Mn |